218 related articles for article (PubMed ID: 431482)
1. [Differential therapy with cellular blood components in internal medicine].
Hoppe I
Med Klin; 1979 May; 74(18):695-700. PubMed ID: 431482
[No Abstract] [Full Text] [Related]
2. [Substitution and protective therapy with blood components].
Dietzfelbinger H; Woitinas F
Med Klin; 1979 May; 74(18):680-5. PubMed ID: 431481
[No Abstract] [Full Text] [Related]
3. [Principal clinical indications for direct transfusion therapy].
Silvestri G; Radicioni P
Minerva Med; 1977 Sep; 68(42):2983-92. PubMed ID: 909645
[TBL] [Abstract][Full Text] [Related]
4. Optimal use of blood components and derivatives.
Walter WJ; Oberman HA
Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
[No Abstract] [Full Text] [Related]
5. Blood component therapy in neonatal medicine.
Lenes BA; Sacher RA
Clin Lab Med; 1981 Jun; 1(2):285-309. PubMed ID: 6809397
[No Abstract] [Full Text] [Related]
6. New trends in blood component therapy.
Högman CF
Haematologia (Budap); 1983; 16(1-4):23-38. PubMed ID: 6383964
[No Abstract] [Full Text] [Related]
7. [Supportive treatment in hemopathies].
Juliá Font A
Sangre (Barc); 1984; 29(4-C):668-73. PubMed ID: 6440299
[No Abstract] [Full Text] [Related]
8. [Supportive hemotherapy in anemias].
Haustein B; Helbig W
Z Gesamte Inn Med; 1978 May; 33(9):289-92. PubMed ID: 676413
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the practice and technology of blood transfusion.
Sandler SG
Prim Care; 1980 Sep; 7(3):347-67. PubMed ID: 6777791
[No Abstract] [Full Text] [Related]
10. Autoimmune hemolytic anemia in children.
Bikowski RM; Mitchell JE
Am Fam Physician; 1982 Aug; 26(2):131-4. PubMed ID: 7102492
[TBL] [Abstract][Full Text] [Related]
11. [Current status of transfusion medicine].
Höcker P
Infusionsther Klin Ernahr; 1985 Aug; 12(4):163-9. PubMed ID: 2866159
[TBL] [Abstract][Full Text] [Related]
12. Transfusion support for leukaemia and oncology patients.
Mayer K
Clin Haematol; 1984 Feb; 13(1):93-8. PubMed ID: 6373084
[No Abstract] [Full Text] [Related]
13. [Practical remarks on the diagnosis and treatment of autoimmunohemolytic anemias].
Zupańska B
Pol Tyg Lek; 1982 Apr; 37(8):239-42. PubMed ID: 7111091
[No Abstract] [Full Text] [Related]
14. [Intensive plasmapheresis and erythropheresis, an emergency treatment of superacute autoimmune anemia].
Herrera A; Bernard JF; Vroclans M; Dhermy D; Renoux M; Bolvin P
Nouv Presse Med; 1980 Jan; 9(5):317. PubMed ID: 7355120
[No Abstract] [Full Text] [Related]
15. Transfusion therapy in autoimmune hemolytic anemia.
Jefferies LC
Hematol Oncol Clin North Am; 1994 Dec; 8(6):1087-104. PubMed ID: 7860438
[TBL] [Abstract][Full Text] [Related]
16. [Targetted hemotherapy with special reference to the cellular components].
Dörner R
Dtsch Med Wochenschr; 1990 Jul; 115(27):1066-72. PubMed ID: 2194776
[No Abstract] [Full Text] [Related]
17. [Stability of blood cell preparations for malignant blood diseases].
Kekomäki R
Duodecim; 1989; 105(11):1138-47. PubMed ID: 2666096
[No Abstract] [Full Text] [Related]
18. [Use of large doses of cryopreserved erythrocytes in treating anemia in liver cirrhosis].
Zhuravlev VA; Sukhorukov VP; Biteev VKh
Probl Gematol Pereliv Krovi; 1980 Dec; 25(12):22-4. PubMed ID: 7208453
[No Abstract] [Full Text] [Related]
19. Selective transfusion of blood components.
McCredie KB
Int Adv Surg Oncol; 1981; 4():145-71. PubMed ID: 7019094
[No Abstract] [Full Text] [Related]
20. [Remarks and considerations concerning transfusion therapy in hemolytic autoimmune anemias].
Dazzi L; Zanini S
Riv Emoter Immunoematol; 1967; 14(3):101-18. PubMed ID: 5601680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
